For patients with immune effector cell-associated neurotoxicity syndrome (ICANS) due to chimeric antigen receptor (CAR) T-cell therapy, electroencephalogram (EEG) has the greatest therapeutic impact, according to a study ...
Apr 8, 2024
0
0
Junior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) and a collaborative team of researchers in Japan recently characterized SARS-CoV-2 collected from a persistent COVID-19 patient to ...
Apr 3, 2024
0
52
As we age, the immune system's efficacy weakens, leading to less effective defenses against new pathogens—such as the SARS-CoV-2 virus. How immunosenescence in older adults affects their immune response to COVID-19 mRNA ...
Apr 3, 2024
0
0
Cancer cells release a significantly more concentrated level of acid than previously known, forming an "acid wall" that could deter immune cells from attacking tumors, UT Southwestern Medical Center scientists show in a new ...
Apr 2, 2024
0
270
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective ...
Apr 2, 2024
0
26
Researchers at Tel Aviv University developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer patients. Using both an animal model and tissue samples from patients in Israel ...
Apr 2, 2024
0
35
Early in 2024, reports of a fatal case of Alaskapox were circulating in the news. A little-known virus with few cases to its name, Alaskapox virus triggers the eruption of 1 or more skin lesions on the body, among other symptoms. ...
Apr 1, 2024
0
1
A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the ...
Mar 29, 2024
0
50
It is currently unclear where T cells in the brains of teleosts originate from. While viewing the central nervous system (CNS) as immune privileged has been widely accepted, previous studies suggest that T cells residing ...
Mar 27, 2024
0
1
A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic cells directly into cancerous lung tumors can help promote a stronger immune response, causing more ...
Mar 26, 2024
0
0
